Proteomic approach to studying parkinson’s disease

ISSN： 0893-7648

Source： Molecular Neurobiology, Vol.29, Iss.3, 2004-06, pp. : 271-288

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene therapy for Parkinson’s disease

By Le Hoang N Frim David M

Expert Opinion on Biological Therapy, Vol. 2, Iss. 2, 2002-02 ,pp. : 151-161

Informa Healthcare

Access to resources Recommend Favorite

Environmental toxins and α-synuclein in Parkinson’s disease

By Liu Yanying Yang Hui

Molecular Neurobiology, Vol. 31, Iss. 1-3, 2005-02 ,pp. : 273-282

Humana Press, Inc

Access to resources Recommend Favorite

Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson’s disease

By Bonsi P. Cuomo D. Picconi B. Sciamanna G. Tscherter A. Tolu M. Bernardi G. Calabresi P. Pisani A.

Amino Acids, Vol. 32, Iss. 2, 2007-02 ,pp. : 189-195

Springer Publishing Company

Access to resources Recommend Favorite

Neurorestoration in Parkinson’s disease by cell replacement and endogenous regeneration

By Hermann Andreas Gerlach Manfred Schwarz Johannes Storch Alexander

Expert Opinion on Biological Therapy, Vol. 4, Iss. 2, 2004-02 ,pp. : 131-143

Informa Healthcare

Access to resources Recommend Favorite

Embryonic stem cells as a cell source for treating Parkinson’s disease

By Fukuda Hitoshi Takahashi Jun

Expert Opinion on Biological Therapy, Vol. 5, Iss. 10, 2005-10 ,pp. : 1273-1280

Informa Healthcare

Access to resources Recommend Favorite